Bellevue Group’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$1.46M Sell
2022
Q2
$2.51M Hold
2022
Q1
$4.17M Hold
2021
Q4
$5.12M Hold
2021
Q3
$8.05M Hold
2021
Q2
$12.1M Buy